Abstract:Background Elevated inflammatory cytokines seen in multiple sclerosis (MS) promote cerebrovascular stress and provoke endothelial disturbances. Despite the high metabolic rate of neurons and their sensitivity to the local environmental milieu, the brain lacks a ‘conventional’ lymphatic system, which in peripheral tissues aids in clearance of metabolic wastes and immune cells. Recently changes in lymphatic‐venous biomarkers have been observed in human brain tissue and serum in MS. Whether and how these molecular features might contribute to clearance of fluid and debris remains unclear, but the transfer of lymphatic venous proteins from brain endothelial cells (‘BEC’) to MPs during neuroinflammation could represent a valuable marker and mediator of neurovascular stress. Objective We determined the individual and combined effects of pro‐inflammatory cytokines tumor necrosis factor‐α (TNF‐α) and interferon‐γ (IFN‐γ) on the expression levels of lymphatic‐venous biomarkers including lymphatic vessel endothelial hyaluronan receptor (LYVE‐1), Prospero Homeobox‐1 (Prox‐1), forkhead box C2 (FoxC2), vascular endothelial growth factor receptor‐3 (VEGFR‐3) and podoplanin in murine BEC as well as in microparticles (MPs) derived from these cells. Methods Murine BEC, bEnd.3, were treated with TNF‐α (20 ng/ml) and/or IFN‐γ (1000 U/ml) for 48 hours. The number of MPs shed from cells under different treatment conditions were analyzed using flow cytometry. Levels of lymphatic‐venous biomarker expressions were determined in both cells and MPs using western blotting. Expression patterns of these proteins were examined using immunocytochemistry. Fluorescently labeled BODIPY‐cholesterol was used to observe cholesterol partitioning of cellular membranes into MPs. Results Several lymphatic‐venous biomarkers were basally expressed by bEnd.3 cells and transferred into endothelial MPs following TNF‐α/IFN‐γ stimulation. IFN‐γ treatment caused a significant decrease of LYVE‐1 ( p <0.01), VEGFR‐3 ( p <0.01) as well as Prox‐1 ( p <0.01). TNF‐α significantly increased podoplanin ( p <0.05) and VEGFR‐3 ( p <0.05) levels in the cells. Following combined treatment MP LYVE‐1 increased significantly ( p <0.01) but decreased in cells ( p <0.05). Combined treatment also significantly decreased cellular Prox‐1 levels ( p <0.001). Combined stimulation also potently induced transfer of caveolin‐1 into MPs, measured as a significant decrease in cells ( p <0.05) and increase in MPs ( p <0.05). Similarly, TNF‐α/IFN‐γ stimulated bEnd.3 cells to shed membrane cholesterol, (measured by BODIPY‐cholesterol) consistent with endothelial MP identity as caveolae released by cytokine‐activated BEC. Conclusion These findings show that pro‐inflammatory cytokines alter lymphatic‐venous proteins as well as caveolar partitioning from BEC into MPs; such events may represent important indices of neurovascular/neurodegenerative disease. Support or Funding Information Supported by the Annette Funicello Research Fund for Neurologic Research and the Department of Neurology, Louisiana State Univeristy Health Sciences Center ‐ Shreveport

TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier

Regulation of Neuroinflammation: What Role for the Tumor Necrosis Factor-Like Weak Inducer of Apoptosis/Fn14 Pathway?

The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system

Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions

TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model

The TNFSF12/TWEAK Modulates Colonic Inflammatory Fibroblast Differentiation and Promotes Fibroblast-Monocyte Interactions

TWEAK/Fn14 Pathway is a Novel Mediator of Retinal Neovascularization.

Modeling of Blood–Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research

Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis

Neuropilin-1 Modulates Interferon-Γ-stimulated Signaling in Brain Microvascular Endothelial Cells.

A transcriptomic analysis of cerebral microvessels reveals the involvement of Notch1 signaling in endothelial mitochondrial-dysfunction-dependent BBB disruption

A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood-brain barrier model

TWEAK/Fn14 Activation Participates in Skin Inflammation.

TWEAK/Fn14 Activation Participates in Skin Inflammation

Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.

Brain Endothelial Cells Segregate Lymphatic‐Venous Biomarkers into Microparticles Following Inflammatory Cytokine Stimulation

Systemic inflammation modulates the levels of EBI2 and 7α,25-OHC synthesizing (CH25H, CYP7B1) and degrading (HSD3B7) enzymes in brain microvascular cells

Establishment of a novel amyotrophic lateral sclerosis patient (TARDBP N345K/+)-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction

TWEAK promotes endothelial progenitor cell vasculogenesis to alleviate acute myocardial infarction via the Fn14-NF-κB signaling pathway.

Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction

Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model